Clairity Inc.
Clairity Inc.'s AI Breakthrough Poised to Revolutionize Breast Cancer Risk Prediction
Clairity Inc. is set to transform the landscape of early breast cancer detection with its groundbreaking AI-powered risk prediction technology, Clairity Breast. Having secured De Novo authorization from the U.S. Food and Drug Administration (FDA) in late May 2025, this innovative platform is the first artificial intelligence tool authorized